Whitehawk Therapeutics Inc
Research Whitehawk Therapeutics Inc (WHWK) on Bullrun: market cap USD 289.61M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWHWK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 289.61M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 16.64M
- Free cash flow-USD 14.53M
Valuation Snapshot
latest market cap is USD 289.61M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.15M | -USD 20.60M | -USD 97.99M | 89.4% | -0.33 | USD 37.57M | USD 0 | USD 136.31M |
| FY2024 | USD 25.98M | -USD 63.69M | -USD 61.20M | 88.4% | -2.36 | USD 28.67M | USD 833.00K | USD 52.48M |
| FY2023 | USD 24.35M | -USD 65.77M | -USD 63.64M | 88.5% | -2.44 | USD 62.89M | USD 1.27M | USD 105.20M |
| FY2022 | USD 15.22M | -USD 60.51M | -USD 50.08M | 91.2% | -2.69 | USD 39.02M | n/a | USD 158.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 289.61M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 114.09M | 5.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 77.74M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 49.54M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 312.99M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 504.61M | n/a | n/a | n/a |
About Whitehawk Therapeutics Inc
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Whitehawk Therapeutics Inc's market cap?
Whitehawk Therapeutics Inc's market capitalization is USD 289.61M.
What does Whitehawk Therapeutics Inc do?
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.